# Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral Regurgitation

> **NCT06414265** · NA · RECRUITING · sponsor: **InnovHeart** · enrollment: 30 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Transcatheter mitral valve replacement

## Key facts

- **NCT ID:** NCT06414265
- **Lead sponsor:** InnovHeart
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-04
- **Primary completion:** 2027-03
- **Final completion:** 2030-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414265, "Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral Regurgitation". Retrieved via AI Analytics 2026-08-14 from https://api.ai-analytics.org/clinical/NCT06414265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*